(5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine

C37H63N7 — CID 164621683

IUPAC(5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine
SMILES[H]/N=C1\N(CC2CCC(C(C)(C)C)CC2)[C@H](CCC)CN1[C@H](Cc1ccccc1)N1CCC[C@H]1CN1C(N)=NC[C@H]1CC(C)C
InChIInChI=1S/C37H63N7/c1-7-12-31-26-44(36(39)43(31)24-29-16-18-30(19-17-29)37(4,5)6)34(22-28-13-9-8-10-14-28)41-20-11-15-32(41)25-42-33(21-27(2)3)23-40-35(42)38/h8-10,13-14,27,29-34,39H,7,11-12,15-26H2,1-6H3,(H2,38,40)/b39-36+/t29?,30?,31-,32+,33-,34-/m1/s1
InChIKeyILJUOCVHINDNPZ-DAIXBHBXSA-N
MW605.96 g/mol
LogP6.64
Rot. Bonds12

About (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine

(5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine (PubChem CID 164621683) has the molecular formula C37H63N7 and a molecular weight of 605.96 g/mol. Its IUPAC name is (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine.

Molecular Properties

Compound Name(5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine
PubChem CID164621683
Molecular FormulaC37H63N7
Molecular Weight605.96 g/mol
Exact Mass605.51
IUPAC Name(5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine
SMILES[H]/N=C1\N(CC2CCC(C(C)(C)C)CC2)[C@H](CCC)CN1[C@H](Cc1ccccc1)N1CCC[C@H]1CN1C(N)=NC[C@H]1CC(C)C
InChIInChI=1S/C37H63N7/c1-7-12-31-26-44(36(39)43(31)24-29-16-18-30(19-17-29)37(4,5)6)34(22-28-13-9-8-10-14-28)41-20-11-15-32(41)25-42-33(21-27(2)3)23-40-35(42)38/h8-10,13-14,27,29-34,39H,7,11-12,15-26H2,1-6H3,(H2,38,40)/b39-36+/t29?,30?,31-,32+,33-,34-/m1/s1
InChIKeyILJUOCVHINDNPZ-DAIXBHBXSA-N
XLogP6.64
TPSA75.19 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds12
Heavy Atoms44
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500605.96
LogP ≤ 56.64
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine?
The IUPAC name of (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine (CID 164621683) is (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine.
What is the SMILES notation for (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine?
The canonical SMILES for (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine is [H]/N=C1\N(CC2CCC(C(C)(C)C)CC2)[C@H](CCC)CN1[C@H](Cc1ccccc1)N1CCC[C@H]1CN1C(N)=NC[C@H]1CC(C)C.
What is the InChIKey of (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine?
The InChIKey is ILJUOCVHINDNPZ-DAIXBHBXSA-N. The full InChI is InChI=1S/C37H63N7/c1-7-12-31-26-44(36(39)43(31)24-29-16-18-30(19-17-29)37(4,5)6)34(22-28-13-9-8-10-14-28)41-20-11-15-32(41)25-42-33(21-27(2)3)23-40-35(42)38/h8-10,13-14,27,29-34,39H,7,11-12,15-26H2,1-6H3,(H2,38,40)/b39-36+/t29?,30?,31-,32+,33-,34-/m1/s1.
What are the key properties of (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine?
(5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine has a molecular weight of 605.96 g/mol, XLogP of 6.64, 12 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-1-[[(2S)-1-[(1R)-1-[(4R)-3-[(4-tert-butylcyclohexyl)methyl]-2-imino-4-propylimidazolidin-1-yl]-2-phenylethyl]pyrrolidin-2-yl]methyl]-5-(2-methylpropyl)-4,5-dihydroimidazol-2-amine is sourced from PubChem (CID 164621683), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).